Human Placental Growth Hormone Variant in Pathological Pregnancies

Endocrinology. 2018 May 1;159(5):2186-2198. doi: 10.1210/en.2018-00037.

Abstract

Growth hormone (GH), an endocrine hormone, primarily secreted from the anterior pituitary, stimulates growth, cell reproduction, and regeneration and is a major regulator of postnatal growth. Humans have two GH genes that encode two versions of GH proteins: a pituitary version (GH-N/GH1) and a placental GH-variant (GH-V/GH2), which are expressed in the syncytiotrophoblast and extravillous trophoblast cells of the placenta. During pregnancy, GH-V replaces GH-N in the maternal circulation at mid-late gestation as the major circulating form of GH. This remarkable change in spatial and temporal GH secretion patterns is proposed to play a role in mediating maternal adaptations to pregnancy. GH-V is associated with fetal growth, and its circulating concentrations have been investigated across a range of pregnancy complications. However, progress in this area has been hindered by a lack of readily accessible and reliable assays for measurement of GH-V. This review will discuss the potential roles of GH-V in normal and pathological pregnancies and will touch on the assays used to quantify this hormone.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Diabetes, Gestational / metabolism
  • Down Syndrome / metabolism
  • Female
  • Fetal Growth Retardation / metabolism
  • Fetal Macrosomia / metabolism
  • Gestational Trophoblastic Disease / metabolism
  • Growth Hormone / metabolism*
  • Humans
  • Placental Hormones / metabolism*
  • Pregnancy
  • Pregnancy Complications / metabolism*
  • Pregnancy in Diabetics / metabolism
  • Pregnancy, Ectopic / metabolism
  • Protein Isoforms
  • Trisomy 18 Syndrome / metabolism

Substances

  • GH2 protein, human
  • Placental Hormones
  • Protein Isoforms
  • Growth Hormone